Snowden Capital Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-5,360
Closed -$224K – 1179
2023
Q1
$224K Buy
5,360
+8
+0.1% +$337 0.01% 1042
2022
Q4
$233K Buy
5,352
+8
+0.1% +$340 0.01% 1013
2022
Q3
$207K Buy
5,344
+8
+0.1% +$341 0.01% 1023
2022
Q2
$226K Buy
5,336
+10
+0.2% +$434 0.01% 989
2022
Q1
$242K Buy
5,326
+3,476
+188% +$154K 0.01% 904
2021
Q4
$89K Buy
+1,850
New +$87.6K ﹤0.01% 875

Other funds holding BME

Snowden Capital Advisors's BME Position: Q2 2023 in Review

Snowden Capital Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 5,360 shares — an estimated $224K sold.

Snowden Capital Advisors first reported a position in BME in Q4 2021 and held it in 6 quarters. The position peaked at $242K in Q1 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.

  • Snowden Capital Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
  • Snowden Capital Advisors sold 5,360 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $224K.
  • Snowden Capital Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 6 quarters.
  • Snowden Capital Advisors's BlackRock Health Sciences Trust position peaked at $242K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.

Based on Snowden Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.